These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 24626525)
21. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf. Marzec M; Kasprzycka M; Liu X; Raghunath PN; Wlodarski P; Wasik MA Oncogene; 2007 Feb; 26(6):813-21. PubMed ID: 16909118 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells. Anders M; Christian C; McMahon M; McCormick F; Korn WM Cancer Res; 2003 May; 63(9):2088-95. PubMed ID: 12727824 [TBL] [Abstract][Full Text] [Related]
23. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Liu L; Cao Y; Chen C; Zhang X; McNabola A; Wilkie D; Wilhelm S; Lynch M; Carter C Cancer Res; 2006 Dec; 66(24):11851-8. PubMed ID: 17178882 [TBL] [Abstract][Full Text] [Related]
24. Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo. Ouyang B; Knauf JA; Smith EP; Zhang L; Ramsey T; Yusuff N; Batt D; Fagin JA Clin Cancer Res; 2006 Mar; 12(6):1785-93. PubMed ID: 16551863 [TBL] [Abstract][Full Text] [Related]
25. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors. Marampon F; Ciccarelli C; Zani BM Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113 [TBL] [Abstract][Full Text] [Related]
26. NBS1 is required for IGF-1 induced cellular proliferation through the Ras/Raf/MEK/ERK cascade. Hematulin A; Sagan D; Eckardt-Schupp F; Moertl S Cell Signal; 2008 Dec; 20(12):2276-85. PubMed ID: 18793719 [TBL] [Abstract][Full Text] [Related]
27. Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPARγ signalling pathway. Wang G; Cao R; Wang Y; Qian G; Dan HC; Jiang W; Ju L; Wu M; Xiao Y; Wang X Sci Rep; 2016 Oct; 6():35783. PubMed ID: 27779188 [TBL] [Abstract][Full Text] [Related]
28. Raf-1 kinase activation is uncoupled from downstream MEK/ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2. Lee M Biochem Biophys Res Commun; 2006 Nov; 350(2):450-6. PubMed ID: 17010316 [TBL] [Abstract][Full Text] [Related]
29. Notch-1 regulates proliferation and differentiation of human bladder cancer cell lines by inhibiting expression of Krüppel-like factor 4. Ai X; Jia Z; Liu S; Wang J; Zhang X Oncol Rep; 2014 Oct; 32(4):1459-64. PubMed ID: 25109409 [TBL] [Abstract][Full Text] [Related]
30. Raf-1 causes growth suppression and alteration of neuroendocrine markers in DMS53 human small-cell lung cancer cells. Ravi RK; Thiagalingam A; Weber E; McMahon M; Nelkin BD; Mabry M Am J Respir Cell Mol Biol; 1999 Apr; 20(4):543-9. PubMed ID: 10100985 [TBL] [Abstract][Full Text] [Related]
31. Capsaicin induces cycle arrest by inhibiting cyclin-dependent-kinase in bladder carcinoma cells. Chen D; Yang Z; Wang Y; Zhu G; Wang X Int J Urol; 2012 Jul; 19(7):662-8. PubMed ID: 22462738 [TBL] [Abstract][Full Text] [Related]
32. Sinodielide A exerts thermosensitizing effects and induces apoptosis and G2/M cell cycle arrest in DU145 human prostate cancer cells via the Ras/Raf/MAPK and PI3K/Akt signaling pathways. Hatashita M; Taniguchi M; Baba K; Koshiba K; Sato T; Jujo Y; Suzuki R; Hayashi S Int J Mol Med; 2014 Feb; 33(2):406-14. PubMed ID: 24285252 [TBL] [Abstract][Full Text] [Related]
33. PI3K-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival. Coutant A; Rescan C; Gilot D; Loyer P; Guguen-Guillouzo C; Baffet G Hepatology; 2002 Nov; 36(5):1079-88. PubMed ID: 12395317 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib--the role of extracellular signal-regulated kinase counteraction. Manov I; Pollak Y; Broneshter R; Iancu TC FEBS J; 2011 Sep; 278(18):3494-507. PubMed ID: 21790999 [TBL] [Abstract][Full Text] [Related]
35. hepaCAM and p-mTOR closely correlate in bladder transitional cell carcinoma and hepaCAM expression inhibits proliferation via an AMPK/mTOR dependent pathway in human bladder cancer cells. Wang Q; Luo C; Wu X; Du H; Song X; Fan Y J Urol; 2013 Nov; 190(5):1912-8. PubMed ID: 23669565 [TBL] [Abstract][Full Text] [Related]
36. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells. Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520 [TBL] [Abstract][Full Text] [Related]
37. Xanthoceraside induces apoptosis in melanoma cells through the activation of caspases and the suppression of the IGF-1R/Raf/MEK/ERK signaling pathway. Jiao Q; Zou L; Liu P; Xu Q; Zhang Y; Yu Y; Zou L; Chi T; Ji X J Med Food; 2014 Oct; 17(10):1070-8. PubMed ID: 25116791 [TBL] [Abstract][Full Text] [Related]
38. Boldine induces cell cycle arrest and apoptosis in T24 human bladder cancer cell line via regulation of ERK, AKT, and GSK-3β. Gerhardt D; Bertola G; Dietrich F; Figueiró F; Zanotto-Filho A; Moreira Fonseca JC; Morrone FB; Barrios CH; Battastini AM; Salbego CG Urol Oncol; 2014 Jan; 32(1):36.e1-9. PubMed ID: 24239461 [TBL] [Abstract][Full Text] [Related]
39. The tumor-suppressor gene Nkx2.8 suppresses bladder cancer proliferation through upregulation of FOXO3a and inhibition of the MEK/ERK signaling pathway. Yu C; Zhang Z; Liao W; Zhao X; Liu L; Wu Y; Liu Z; Li Y; Zhong Y; Chen K; Li J; Zhou F; Song L Carcinogenesis; 2012 Mar; 33(3):678-86. PubMed ID: 22223847 [TBL] [Abstract][Full Text] [Related]
40. In vitro anticancer effects of esculetin against human leukemia cell lines involves apoptotic cell death, autophagy, G0/G1 cell cycle arrest and modulation of Raf/MEK/ERK signalling pathway. Wang X; Yang C; Zhang Q; Wang C; Zhou X; Zhang X; Liu S J BUON; 2019; 24(4):1686-1691. PubMed ID: 31646826 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]